Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/13960
Title: Pharmacokinetics and organ distribution of diarylheptanoid phytoestrogens from Curcuma comosa in rats
Authors: Jian Su
Kittisak Sripanidkulchai
Apichart Suksamrarn
Ying Hu
Pawinee Piyachuturawat
Bungorn Sripanidkulchai
Khon Kaen University
Ramkhamhaeng University
Mahidol University
Keywords: Chemistry;Medicine;Pharmacology, Toxicology and Pharmaceutics
Issue Date: 1-Jul-2012
Citation: Journal of Natural Medicines. Vol.66, No.3 (2012), 468-475
Abstract: Curcuma comosa is widely used as a traditional herbal medicine for gynecological diseases in South East Asia. Previous studies reported that it has phytoestrogenic activity, and several diarylheptanoids were found to be the active constituents. In this study, the pharmacokinetics profile and organ distribution of three active compounds of C. comosa hexane extract were investigated. Rats were separately administered C. comosa hexane extract intravenously at the dose of 125 mg/kg and orally at the doses of 125 and 250 mg/kg body weight, after which blood and target organs were collected at specified time intervals from 0 to 24 h. HPLC was used to measure the concentration of three major compounds, (6E)-1,7-diphenylhept-6-en-3-one (DPH1), (4E,6E)-1,7-diphenylhepta-4,6-dien-3-ol (DPH2), and (6E)-1,7-diphenylhept-6-en- 3-ol (DPH3), which were found to be present in the blood and tissues and were subsequently used as markers. In the intravenous study, the volumes of distribution (Vd) were 1.06, 8.57, and 6.56 L/kg and clearance values (CLs) were 0.28, 5.56, and 3.39 L/kg/h for DPH1, DPH2, and DPH3, respectively. After oral administration, the three major compounds of both doses reached a maximum systemic concentration at 2 h with maximum concentration (Cmax) of 0.85, 0.17, and 0.53 mg/L for the lower dose and 1.46, 0.17, and 0.61 mg/L for the higher dose. The bioavailabilities were 31.2, 24.01, and 31.56% for lower dose and 22.61, 17.66, and 17.73% for higher dose with a terminal half-life (t1/2) of 10.86, 6.3, and 4.62 h for lower dose and 3.85, 2.77, and 2.10 h for higher dose for DPH1, DPH2, and DPH3, respectively. These three major compounds are all found distributed in the brain, liver, kidneys, ovaries, and uterus after oral and intravenous administration and their related pharmacokinetic parameters are described. This study provides the essential pharmacokinetic data for diarylheptanoid phytoestrogenic compounds of C. comosa extract which are required for clinical dose and dosage design. © The Japanese Society of Pharmacognosy and Springer 2011.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863528007&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/13960
ISSN: 18610293
13403443
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.